Network Insights Methodology Whitepaper Get Access

Eli Lilly

PERSON Health Care / Pharmaceutical Products & Services Momentum 6.7ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. ELEVATEDPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

$787B market cap (Indianapolis) manufactures insulin, GLP-1 agonists (Mounjaro, Tirzepatide), and oncology drugs. Ken Griffin accumulated shares in Q4 2024, signaling confidence in obesity drug pipeline and margin expansion.

Recent institutional investment by Ken Griffin's Citadel; stock accumulation signals potential M&A interest or activist positioning in pharma sector.
1.45
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
6.7
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
45
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
Eli Lilly is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Connected Entities
Novo Nordisk FDA NYSE PlocamiumAI Morgan Stanley China Merck Wall Street HHS AstraZeneca Nvidia Washington Apple Americans JPMorgan Chase
Watch This Entity
PSI Intelligence
30-Day Trend
2026-08-09 2026-09-04 47 0 Degree Mentions
Signal Decomposition
Attention Cascade
3.333
Narrative Drift
0.153
Spectral Shift
546.285
Sentiment-Momentum Divergence
0.000
Source Concentration
0.256
Signal
Eli Lilly is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Driver
Ranked #1 of 71 in Health Care — sector outlier (2.6 sigma above median). PSI down 0.20 from yesterday (1.06 -> 0.86).
Action
Baseline conditions. Continue standard monitoring cadence.
Peer Comparison
1 of 71
Sector Rank
+2.55
Peer Z-Score
100%
Sector Percentile
Network Analysis
45 Degree Centrality
Ego Network (top connections)
Novo Nordisk (weight 41.0)FDA (weight 29.0)NYSE (weight 27.0)PlocamiumAI (weight 20.0)Morgan Stanley (weight 18.0)China (weight 16.0)Merck (weight 13.0)Wall Street (weight 10.0) Novo NordiskFDANYSEPlocamiumAIMorgan StanleyChinaMerckWall Street Eli Lilly (degree 45) Eli Lilly
Centrality History
2026-08-09 2026-09-04 47 0 Degree Mentions
EntityWeight StatusFirst Seen
Novo Nordisk 41 NEW
FDA 29 NEW
NYSE 27 NEW
PlocamiumAI 20 NEW
Morgan Stanley 18 NEW
China 16 NEW
Merck 13 NEW
Wall Street 10 NEW
HHS 9 NEW
AstraZeneca 8 NEW
Nvidia 8 NEW
Washington 7 NEW
Apple 6 NEW
Americans 6 NEW
JPMorgan Chase 6 NEW
Europe 5 NEW
Alphabet 5 NEW
SpaceX 5 NEW
United States 5 NEW
CEO 4 NEW
Reuters 4 NEW
Amazon 4 NEW
Microsoft 4 NEW
Walmart 4 NEW
Bloomberg 4 NEW
Beijing 3 NEW
Novartis 3 NEW
Hong Kong 3 NEW
Goldman Sachs 3 NEW
Berkshire Hathaway 3 NEW
Article Coverage (2)
DateLaneTitle
2026-08-13 Healthcare M&A Gene Editing Pioneer Sangamo Fetches 85 Percent Less Than Peak as Bankruptcy Auction Ends
2026-08-12 Healthcare Marketing Lilly Escalates Patent Fight Over Retatrutide as Knockoff Sales Threaten Profit

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-09-04 ← Intelligence Network